Celularity (CELU) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Celularity (CELU) has outperformed Instil Bio (TIL) over the past year, losing 32.1% versus a loss of 68.0%. Over five years, CELU leads with a -98.0% price change compared with -98.2% for TIL. Celularity is the larger company by market cap ($47.4 million vs $44.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CELU | TIL |
|---|---|---|
| Share price | $1.46 | $6.56 |
| Market cap | $47.38M | $44.49M |
| 1-day change | -0.68% | -4.23% |
| YTD return | +31.53% | -40.36% |
| 1-year return | -32.09% | -68.05% |
| 5-year return | -97.97% | -98.17% |
| EPS (TTM) | $-2.73 | $-4.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.55 | $21.98 |
| 52-week low | $0.56 | $5.67 |
| Distance from 52-week high | -42.75% | -70.15% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +6.71% |
| Average volume | 3.89M | 12.54K |
| Shares outstanding | 32.45M | 6.78M |
| Employees | 115 | 17 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CELU has outperformed TIL by 36.0 percentage points over the past year.
About Celularity
CELU stock →Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking.
Healthcare · Biotechnology · 115 employees
About Instil Bio
TIL stock →Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.
Healthcare · Biotechnology · 17 employees
CELU vs TIL FAQ
Which is bigger, Celularity or Instil Bio?
Celularity (CELU) is larger, with a market capitalization of $47.38M compared with $44.49M for Instil Bio (TIL).
Which stock has performed better over the past year, CELU or TIL?
CELU returned -32.09% over the past 12 months, compared with -68.05% for TIL (price return, excluding dividends). Past performance does not predict future results.
Are Celularity and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.